Systematic efforts are underway to decipher the genetic changes associated with tumor
initiation and progression 1 , 2 . However, widespread clinical application of this information is …

Human non–small cell lung cancers (NSCLCs) with activating mutations in EGFR frequently
respond to treatment with EGFR-targeted tyrosine kinase inhibitors (TKIs), such as erlotinib, …

Array manufacturers originally designed single nucleotide polymorphism (SNP) arrays to
genotype human DNA at thousands of SNPs across the genome simultaneously. In the decade …

The sensitivity of conventional DNA sequencing in tumor biopsies is limited by stromal
contamination and by genetic heterogeneity within the cancer. Here, we show that microreactor-…

To elucidate differential roles of mutations in myelodysplastic syndromes (MDS), we
investigated clonal dynamics using whole-exome and/or targeted sequencing of 699 patients, of …

Motivation: The advent of next-generation sequencing (NGS) techniques presents many
novel opportunities for many applications in life sciences. The vast number of short reads …

Germline determinants of gene expression in tumors are infrequently studied due to the
complexity of transcript regulation caused by somatically acquired alterations. We performed …

Somatic genetic alterations in cancers have been linked with response to targeted therapeutics
by creation of specific dependency on activated oncogenic signaling pathways. However…

Cancer is characterized by gene expression aberrations. Studies have largely focused on
coding sequences and promoters, even though distal regulatory elements play a central role …

CHD7 is one of nine members of the chromodomain helicase DNA–binding domain family
of ATP–dependent chromatin remodeling enzymes found in mammalian cells. De novo …